Disease Activity in Mitral Annular Calcification A Multimodality Study

被引:61
|
作者
Massera, Daniele [1 ]
Trivieri, Maria G. [2 ]
Andrews, Jack P. M. [3 ]
Sartori, Samantha [2 ]
Abgral, Ronan [4 ]
Chapman, Andrew R. [3 ]
Jenkins, William S. A. [3 ]
Vesey, Alex T. [3 ]
Doris, Mhairi K. [3 ]
Pawade, Tania A. [3 ]
Zheng, Kang H. [5 ]
Kizer, Jorge R. [6 ,7 ]
Newby, David E. [3 ]
Dweck, Marc R. [3 ]
机构
[1] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Cardiol, New York, NY 10029 USA
[3] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[4] Univ Hosp Brest, Dept Nucl Med, Brest, France
[5] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands
[6] San Francisco Vet Affairs Hlth Care Syst, Cardiol Sect, San Francisco, CA USA
[7] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
基金
英国惠康基金;
关键词
disease progression; inflammation; mitral valve; positron emission tomography computed tomography; AORTIC-VALVE SCLEROSIS; INFLAMMATION; ASSOCIATION; STENOSIS; HEART; BONE; SKELETON; DENSITY; CALCIUM; ADULTS;
D O I
10.1161/CIRCIMAGING.118.008513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Mitral annular calcification (MAC) is associated with cardiovascular events and mitral valve dysfunction. However, the underlying pathophysiology remains incompletely understood. In this prospective longitudinal study, we used a multimodality approach including positron emission tomography, computed tomography, and echocardiography to investigate the pathophysiology of MAC and assess factors associated with disease activity and progression. METHODS: A total of 104 patients (age 72 +/- 8 years, 30% women) with calcific aortic valve disease, therefore predisposed to MAC, underwent F-18-sodium fluoride (calcification activity) and F-18-Fluorodeoxyglucose (inflammation activity) positron emission tomography, computed tomography calcium scoring, and echocardiography. Sixty patients underwent repeat computed tomography and echocardiography after 2 years. RESULTS: MAC (mitral annular calcium score>0) was present in 35 (33.7%) patients who had increased F-18-fluoride (tissue-to-background ratio, 2.32 [95% CI, 1.81-3.27] versus 1.30 [1.22-1.49]; P<0.001) and F-18-Fluorodeoxyglucose activity (tissue-to-background ratio, 1.44 [1.37-1.58] versus 1.17 [1.12-1.24]; P<0.001) compared with patients without MAC. MAC activity (F-18-fluoride uptake) was closely associated with the local calcium score and F-18-Fluorodeoxyglucose uptake, as well as female sex and renal function. Similarly, MAC progression was closely associated with local factors, in particular, baseline MAC. Traditional cardiovascular risk factors and calcification activity in bone or remote atherosclerotic areas were not associated with disease activity nor progression. CONCLUSIONS: MAC is characterized by increased local calcification activity and inflammation. Baseline MAC burden was associated with disease activity and the rate of subsequent progression. This suggests a self-perpetuating cycle of calcification and inflammation that may be the target of future therapeutic interventions.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Genetic predisposition to calcific aortic stenosis and mitral annular calcification
    Kutikhin, Anton G.
    Yuzhalin, Arseniy E.
    Brusina, Elena B.
    Ponasenko, Anastasia V.
    Golovkin, Alexey S.
    Barbarash, Olga L.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (09) : 5645 - 5663
  • [42] The association of the platelet-to-lymphocyte ratio with mitral annular calcification
    Yayla, Cagri
    Akboga, Mehmet Kadri
    Canpolat, Ugur
    Yayla, Kadriye Gayretli
    Kuyumcu, Mevlut Serdar
    Bayraktar, Fatih
    Suleymanoglu, Muhammed
    Aydogdu, Sinan
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2015, 49 (06) : 351 - 356
  • [43] How to Manage Mitral Stenosis Due to Mitral Annular Calcification
    Richard Cheng
    Current Cardiology Reports, 2021, 23
  • [44] Invasive Hemodynamic Predictors of Survival in Patients With Mitral Stenosis Secondary to Mitral Annular Calcification
    El Sabbagh, Abdallah
    Nishimura, Rick A.
    Eleid, Mackram F.
    Pislaru, Sorin, V
    Pellikka, Patricia A.
    Rihal, Charanjit S.
    Guerrero, Mayra
    Hodge, David O.
    Miranda, William R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (10):
  • [45] Mitral Annular Calcification in Obstructive Hypertrophic Cardiomyopathy: Prevalence and Outcomes
    Patlolla, Sri Harsha
    Schaff, Hartzell, V
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Lahr, Brian D.
    Lee, Alexander T.
    Eleid, Mackram F.
    Ommen, Steve R.
    Dearani, Joseph A.
    ANNALS OF THORACIC SURGERY, 2022, 114 (05) : 1679 - 1687
  • [46] Impact of pretransplant mitral annular calcification on the incidence of cardiac events after renal transplantation
    El Hangouche, Nadia
    Gomez, Javier
    Asfaw, Addis
    Sreenivasan, Jayakumar
    Akhtar, Tauseef
    Teshome, Meron
    Vij, Aviral
    Matar, Ralph
    Campagnoli, Tania
    Doukky, Rami
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (03) : 526 - 533
  • [47] Mitral annular calcification: challenges and future perspectives
    Mathias Van Hemelrijck
    Maurizio Taramasso
    Gökhan Gülmez
    Francesco Maisano
    Carlos-A. Mestres
    Indian Journal of Thoracic and Cardiovascular Surgery, 2020, 36 : 397 - 403
  • [48] Prevalence and correlates of mitral annular calcification in adults with chronic kidney disease: Results from CRIC study
    Abd Alamir, Moshrik
    Radulescu, Vlad
    Goyfman, Michael
    Mohler, Emile R., III
    Gao, Yan Lin
    Budoff, Matthew J.
    ATHEROSCLEROSIS, 2015, 242 (01) : 117 - 122
  • [49] Mitral annular calcification: Bad versus worse
    Tanaka, Dustin K.
    Yanagawa, Bobby
    JOURNAL OF CARDIAC SURGERY, 2021, 36 (07) : 2419 - 2420
  • [50] Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease
    Unal, Hilmi Umut
    Celik, Murat
    Gokoglan, Yalcin
    Cetinkaya, Hakki
    Gok, Mahmut
    Karaman, Murat
    Yilmaz, Mahmut Ilker
    Eyileten, Tayfun
    Oguz, Yusuf
    RENAL FAILURE, 2014, 36 (10) : 1481 - 1485